Search Results - "Lange, Sara S."

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy? by Liang, Brooke, Lange, Sara S., Massad, L. Stewart, Dick, Rebecca, Mills, Kathryn A., Hagemann, Andrea R., McCourt, Carolyn K., Thaker, Premal H., Fuh, Katherine C., Mutch, David G., Powell, Matthew A., Kuroki, Lindsay M.

“…To assess the renal outcomes of gynecologic oncology patients who present with hydronephrosis and acute kidney injury (AKI), have <20% renal function on…”
Get full text

Obstetric and Gynecologic Challenges in Women With Ehlers-Danlos Syndrome by Hurst, Bradley S., Lange, Sara S., Kullstam, Susan M., Usadi, Rebecca S., Matthews, Michelle L., Marshburn, Paul B., Templin, Megan A., Merriam, Kathryn S.

“…To determine how often women with Ehlers-Danlos syndrome experience obstetric and gynecologic issues both compared with the general population and within the…”
Get full text

Recent advances in the treatment of sarcomas in gynecology by Lange, Sara S, Novetsky, Akiva P, Powell, Matthew A

“…Uterine sarcomas are a heterologous group of rare malignancies accounting for 8-10% of all uterine malignancies, but are significantly more aggressive and have…”
Get more information

Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102 by Brashears, Caitlyn B, Prudner, Bethany C, Rathore, Richa, Caldwell, Katharine E, Dehner, Carina A, Buchanan, Jane L, Lange, Sara E S, Poulin, Neal, Sehn, Jennifer K, Roszik, Jason, Spitzer, Dirk, Jones, Kevin B, O'Keefe, Regis, Nielsen, Torsten O, Taylor, Eric B, Held, Jason M, Hawkins, William, Van Tine, Brian A

“…To investigate the metabolism of synovial sarcoma (SS) and elucidate the effect of malic enzyme 1 absence on SS redox homeostasis. ME1 expression was measured…”
Get full text

Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications by Lange, Sara E S, Zheleznyak, Alex, Studer, Matthew, O'Shannessy, Daniel J, Lapi, Suzanne E, Van Tine, Brian A

“…The complexity of sarcoma has led to the need for patient selection via in vivo biomarkers. Tumor endothelial marker-1 (TEM-1) is a cell surface marker…”
Get full text

Development of an in vivo TEM-1 PET test for clinical screening applications by Lange, Sara ES, Zheleznyak, Alexander, Studer, Matthew, O'Shannessy, Daniel John, Lapi, Suzanne E, Van Tine, Brian Andrew

“…Abstract only…”
Get full text

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy? by Liang, Brooke, Lange, Sara S, Massad, L Stewart, Dick, Rebecca, Mills, Kathryn A, Hagemann, Andrea R, McCourt, Carolyn K, Thaker, Premal H, Fuh, Katherine C, Mutch, David G, Powell, Matthew A, Kuroki, Lindsay M

“…OBJECTIVETo assess the renal outcomes of gynecologic oncology patients who present with hydronephrosis and acute kidney injury (AKI), have <20% renal function…”
Get full text